GleamWall
中文EN

CATX Perspective Therapeutics, Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 728387 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-16.2%
TTM EPS YoY16.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-45.8%
ROA-37.2%
ROIC (approx.)-44.1%
Asset turnover—

Leverage & solvency

Liabilities / assets19.4%
Debt / equity0.01x
Current ratio5.18x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.88x
Accruals ratio-4.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$84.22M$41.64M
SG&A expense$30.23M$26.61M
Operating income-$113.56M-$90.89M
Pretax income-$104.43M-$80.43M
Income tax-$793,000-$2.10M
Net income-$103.12M-$79.28M
EBITDA-$110.31M-$88.58M
EPS (basic)-1.40-1.23
EPS (diluted)-1.40-1.23
Weighted avg. shares (diluted)73.81M64.42M
Balance sheet
Cash & equivalents$30.63M$61.58M
Short-term investments$114.11M$165.34M
Receivables$6,000$116,000
Current assets$148.39M$231.16M
PP&E, net$76.60M$57.32M
Goodwill—$0
Intangibles$362,000$279,000
Total assets$266.97M$341.10M
Current liabilities$28.68M$18.23M
Long-term debt$1.62M$1.68M
Total debt$1.62M$1.68M
Total liabilities$59.94M$50.43M
Shareholders' equity$207.03M$290.67M
Net debt-$29.00M-$59.90M
Shares outstanding74.34M70.67M
Cash flow statement
Operating cash flow-$82.48M-$18.29M
Capital expenditure$12.75M$54.41M
Free cash flow-$95.23M-$72.71M
Investing cash flow$41.23M-$218.93M
Financing cash flow$10.30M$289.38M
Depreciation & amortization$3.25M$2.31M
Stock-based compensation$8.97M$5.39M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.